News
In response to recent outbreaks of Chikungunya fever, Anbio Biotechnology has announced the launch of its Chikungunya IgM/IgG Rapid Test, offering clinicians and public health authorities a fast, ...
The percentage of emergency department visits in the state due to COVID-like illnesses has gone up for five consecutive weeks.
RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...
The Trump administration continues to change national vaccine policy and slash funding. Here's how one Seattle pharmacy is ...
As New Hampshire’s state epidemiologist, Dr. Benjamin Chan was thrust into the spotlight during the COVID-19 pandemic as he ...
A mosquito-borne virus that leaves victims in crippling pain and has triggered Covid-era restrictions in China is already in ...
The health service has warned that cases of RSV, a leading cause of infant mortality, are steadily rising in some parts of ...
Australia saw a record number of RSV cases last year, and NHS officials have suggested that the Australian winter often ...
For newborns and infants, whose immune systems are still developing, and airways are small, RSV can quickly become serious.
To protect yourself from RSV, practice good hygiene, consider getting a vaccination and be aware of potential risks, says the ...
Research from the UK Health Security Agency (UKHSA) has found the RSV vaccine is 72% effective in preventing hospitalisation ...
SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results